CytomX Therapeutics Therapeutic Antibodies Cancer 2017

CytomX Therapeutics presented an overview of their therapeutic antibody platform technology for cancer treatment. The presentation discusses clinical oncology objectives including improving response rates, reducing toxicity, and enhancing durability of response, positioning their innovation against existing standard-of-care and immunotherapy approaches.